338 related articles for article (PubMed ID: 18936416)
1. Imatinib-induced hand-foot syndrome in a patient with metastatic gastrointestinal stromal tumor.
Battistella M; Frémont G; Vignon-Pennamen MD; Gornet JM; Dubertret L; Viguier M
Arch Dermatol; 2008 Oct; 144(10):1400-2. PubMed ID: 18936416
[No Abstract] [Full Text] [Related]
2. Downstaging of a gastric GIST by neoadjuvant imatinib and endoscopic assisted laparoscopic resection.
Cavaliere D; Vagliasindi A; Mura G; Framarini M; Giorgetti G; Solfrini G; Tauceri F; Padovani F; Milandri C; Dubini A; Ridolfi L; Ricci E; Verdecchia GM
Eur J Surg Oncol; 2007 Oct; 33(8):1044-6. PubMed ID: 17467951
[No Abstract] [Full Text] [Related]
3. Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST.
Alexandrescu DT; Dasanu CA; Farzanmehr H; Kauffman L
Dermatol Online J; 2008 Jul; 14(7):7. PubMed ID: 18718191
[TBL] [Abstract][Full Text] [Related]
4. Severe skin reaction in a patient with gastrointestinal stromal tumor treated with imatinib mesylate.
Ferraresi V; Catricalà C; Ciccarese M; Ferrari A; Zeuli M; Cognetti F
Anticancer Res; 2006; 26(6C):4771-4. PubMed ID: 17214339
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases].
Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M
Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842
[TBL] [Abstract][Full Text] [Related]
6. Metastatic gastrointestinal stromal tumor and hypercalcemia in a patient with ulcerative colitis.
Al-Moundhri MS; Al-Thahli K; Al-Kindy S; Salam J; Rao L
Saudi Med J; 2006 Oct; 27(10):1585-7. PubMed ID: 17013488
[TBL] [Abstract][Full Text] [Related]
7. Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinib.
Hamberg P; de Jong FA; Boonstra JG; van Doorn J; Verweij J; Sleijfer S
J Clin Oncol; 2006 Jun; 24(18):e30-1. PubMed ID: 16782905
[No Abstract] [Full Text] [Related]
8. Use of imatinib mesylate in gastrointestinal stromal tumours: Pan-Birmingham Cancer Network experience.
Wong DW; Lupton SC; Bhatt L; Gross L; Tanière P; Peake DR; Spooner D; Geh JI
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):517-22. PubMed ID: 18514495
[TBL] [Abstract][Full Text] [Related]
9. Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib.
Saponara M; Di Battista M; Lolli C; Pantaleo MA; Azzaroli F; Santini D; Di Scioscio V; Catena F; Astorino M; Maleddu A; Biasco G
Endoscopy; 2009; 41 Suppl 2():E67-8. PubMed ID: 19319786
[No Abstract] [Full Text] [Related]
10. Management of imatinib-related exacerbation of psoriasis in a patient with a gastrointestinal stromal tumour.
Cheng H; Geist DE; Piperdi M; Virk R; Piperdi B
Australas J Dermatol; 2009 Feb; 50(1):41-3. PubMed ID: 19178491
[TBL] [Abstract][Full Text] [Related]
11. Interstitial granulomatous drug reaction to sorafenib.
Martínez-Morán C; Nájera L; Ruiz-Casado AI; Romero-Maté A; Espinosa P; Meseguer-Yebra C; Córdoba S; Borbujo JM
Arch Dermatol; 2011 Sep; 147(9):1118-9. PubMed ID: 21931061
[No Abstract] [Full Text] [Related]
12. Facial hyperpigmentation during imatinib therapy for gastrointestinal stromal tumor.
Hamza I; Gaies E; Kastalli S; Daghfous R; El Aidli S
Therapie; 2014; 69(3):245-7. PubMed ID: 24934821
[TBL] [Abstract][Full Text] [Related]
13. Imatinib and altered bone and mineral metabolism.
Joensuu H; Reichardt P
N Engl J Med; 2006 Aug; 355(6):628; author reply 628-9. PubMed ID: 16903020
[No Abstract] [Full Text] [Related]
14. Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate.
Boruban C; Sencan O; Akmansu M; Atik ET; Ozbek S
Anticancer Drugs; 2007 Sep; 18(8):969-72. PubMed ID: 17667604
[TBL] [Abstract][Full Text] [Related]
15. Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy.
Yang CH; Lin WC; Chuang CK; Chang YC; Pang ST; Lin YC; Kuo TT; Hsieh JJ; Chang JW
Br J Dermatol; 2008 Mar; 158(3):592-6. PubMed ID: 18070211
[TBL] [Abstract][Full Text] [Related]
16. Imatinib-induced pathologic changes including bile duct dilatation in hepatic metastases of gastrointestinal stromal tumor: case report and review of literature.
Lee YS; Lee SH; Choi YJ; Jung ES
J Cancer Res Ther; 2014; 10(3):763-6. PubMed ID: 25313780
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of STI571 for a patient with metastatic gastrointestinal stromal tumor.
Sasaki Y; Niwa Y; Ando N; Otsuka Y; Ohmiya N; Hirooka Y; Itoh A; Furuta S; Goto H
Hepatogastroenterology; 2005; 52(66):1764-7. PubMed ID: 16334774
[TBL] [Abstract][Full Text] [Related]
18. Cystic hepatic metastasis from gastrointestinal stromal tumor prior to imatinib mimicking a liver abscess.
Jain P; Jha AK; Rai RR
J Gastrointestin Liver Dis; 2009 Mar; 18(1):121-2. PubMed ID: 19337651
[No Abstract] [Full Text] [Related]
19. Polyclonal resistance in gastrointestinal stromal tumor treated with sequential kinase inhibitors.
Loughrey MB; Waring PM; Dobrovic A; Demetri G; Kovalenko S; McArthur G
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6205-6; author reply 6206-7. PubMed ID: 17062700
[No Abstract] [Full Text] [Related]
20. Efficacy of imatinib mesylate in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy with epirubicin.
Fiorentini G; Bernardeschi P; De Simone M; Rossi S; Dentico P; Biancalani M; Scuderi S; Vaira M; Palomba A
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):13-6. PubMed ID: 16767899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
